ASP-1929

· Rakuten Medical, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ASP-1929, covering 2024-11-04 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer [Phase 2]

See pricing